Market Place
Sourcing Support
Meitheal Gains Exclusive XENLETA® Commercial License
11 Dec 2024 //
BUSINESSWIRE
Meitheal Pharma Licenses Biosimilars from Hong Kong`s King-Friend
31 Oct 2024 //
CONTRACTPHARMA
Meitheal Acquires Contepo From Nabriva To Expand Specialty Biopharma Portfolio
24 Jul 2024 //
INDIANPHARMAPOST
Meitheal Acquires CONTEPO From Nabriva Therapeutics
18 Jul 2024 //
BUSINESSWIRE
Meitheal Gains Exclusive Licensing for YUSIMRY, a Humira Biosimilar
27 Jun 2024 //
BUSINESSWIRE
Meitheal Pharmaceuticals Announces Recent Business Progress Reinforcing
19 Mar 2024 //
BUSINESSWIRE
Meitheal Announces Expansion of Portfolio of Generic Injectable Products
03 Oct 2023 //
BUSINESSWIRE
Meitheal Announces Agreement for Insulin Biosimilars in the U.S.
21 Sep 2023 //
BUSINESSWIRE
Meitheal Announces Closing of Secured Credit Facility Agreement for Up to $80M
22 Aug 2023 //
BUSINESSWIRE
Meitheal pays Xentria $45M for right to TNF drug in lung disease
27 Jun 2023 //
FIERCE BIOTECH
Meitheal Pharma Announces Membership in Association for Accessible Medicines
02 May 2022 //
BUSINESSWIRE
Enforcement Report - Week of September 22, 2021
22 Sep 2021 //
FDA
Meitheal reports positive data from anticoagulants trial for Covid-19
16 Sep 2021 //
CLINICALTRIALSARENA
Meitheal and Premier: Data from study of Anticoagulant use in COVID-19 Patients
15 Sep 2021 //
BUSINESSWIRE
Enforcement Report - Week of March 3, 2021
03 Mar 2021 //
FDA
Meitheal`s labeling mix-up spurs muscle relaxant recall
01 Feb 2021 //
FIERCEPHARMA
Meitheal Pharma Announces Launch of Enoxaparin Sodium Injection
28 May 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.